Array BioPharma, Inc. To Present At The Wells Fargo Securities 2014 Healthcare Conference
Published: Jun 12, 2014
BOULDER, Colo., June 11, 2014 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Wells Fargo Securities 2014 Healthcare Conference in Boston. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.
Wells Fargo Securities 2014 Healthcare Conference
Ron Squarer, Chief Executive Officer
Wednesday, June 18, 2014
8:20 a.m. Eastern Time
InterContinental Hotel, Boston, MA
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Seven Phase 3 or pivotal studies are already in progress, or are planned to begin this year. These programs include the wholly-owned hematology drug, filanesib (ARRY-520) for multiple myeloma and two partnered cancer drugs, selumetinib (AstraZeneca) and binimetinib (MEK162 / Novartis). For more information on Array, please go to www.arraybiopharma.com.
Array BioPharma Inc.
SOURCE Array BioPharma Inc.
Help employers find you! Check out all the jobs and post your resume.